Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
New research sheds light on where the huntingtin protein ends up inside our cells, and why
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?